BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for Cidara Therapeutics, Inc. (CDTX)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Cidara Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-14
4:05 pm
Purchase		 2024-12-31 13G Cidara Therapeutics, Inc.
CDTX		 BIOTECHNOLOGY VALUE FUND L P 1,093,499
9.990%		 390,373increase
(+55.52%)		 Filing
2024-11-14
4:22 pm
Purchase		 2024-09-30 13G Cidara Therapeutics, Inc.
CDTX		 BIOTECHNOLOGY VALUE FUND L P 703,126
9.990%		 703,126increase
(New Position)		 Filing